Allergan to pay $15M for disclosure failures in wake of hostile takeover bid

Drug company Allergan, headquartered in Dublin, Ireland, has agreed to admit securities law violations and pay a $15 million penalty for disclosure failures in the wake of a hostile takeover bid, the Securities and Exchange Commission announced. Jaclyn Jaeger has more.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.